Back

SOX9 regulates endothelial tip cell specification to promote cerebral and neuroretinal vascularization

Dubrac, A.; Anquetil, T.; Cagnone, G.; howard, j.; Kennepohl, L.; Rodriguez, S.; Larrivee, B.

2026-06-09 developmental biology
10.64898/2026.06.07.730751 bioRxiv
Show abstract

BackgroundTissue vascularization relies on the organotypic specification of endothelial tip cells to interpret local cues and guide angiogenic sprouts into specific tissue compartments. However, the molecular regulators controlling brain and retinal endothelial tip cell identity remain poorly understood. MethodsEndothelial-specific Sox9 loss-of-function mouse was combined with single-cell, spatial, and bulk RNA sequencing analyses of developing mouse brain and retinal vasculature, as well as experimental ischemic stroke. Transcriptomic findings were validated using in situ hybridization, immunofluorescence, and functional angiogenesis assays. ResultsTranscription factor activity analysis of single-cell RNA-sequencing datasets identified SOX9 as a candidate regulator selectively enriched in developing brain and retinal endothelial tip cells. Endothelial-specific deletion of Sox9 impaired brain and neuroretina vascularization and disrupted the tip cell transcriptomic program, resulting in reduced sprouting angiogenesis and matrix-remodeling pathways. Conversely, SOX9 overexpression in HUVECs promoted neuro-tip-like signatures and enhanced endothelial invasion and sprouting. Following ischemic stroke, single-cell and spatial transcriptomic analyses identified a transient angiogenic endothelial population within the ischemic area. However, these cells failed to express Sox9 and lacked key developmental brain tip cell features. ConclusionsSOX9 is a key regulator of endothelial tip cell identity and neuronal angiogenesis. These findings reveal fundamental differences between developmental and injury-induced vascular responses and identify SOX9 as a potential therapeutic target to promote functional vascular regeneration.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
npj Regenerative Medicine
24 papers in training set
Top 0.1%
9.8%
2
Cardiovascular Research
37 papers in training set
Top 0.1%
7.9%
3
Arteriosclerosis, Thrombosis, and Vascular Biology
71 papers in training set
Top 0.3%
6.7%
4
Nature Communications
5641 papers in training set
Top 27%
5.5%
5
Cell Reports
1498 papers in training set
Top 6%
5.5%
6
JCI Insight
277 papers in training set
Top 1%
4.8%
7
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 12%
4.4%
8
Development
497 papers in training set
Top 2%
4.3%
9
Circulation Research
47 papers in training set
Top 0.4%
4.0%
50% of probability mass above
10
Scientific Reports
3612 papers in training set
Top 38%
2.8%
11
Journal of the American Heart Association
140 papers in training set
Top 2%
2.8%
12
The FASEB Journal
194 papers in training set
Top 2%
2.4%
13
PLOS ONE
5266 papers in training set
Top 43%
2.4%
14
eLife
5828 papers in training set
Top 41%
2.4%
15
Angiogenesis
14 papers in training set
Top 0.1%
1.7%
16
Developmental Cell
196 papers in training set
Top 2%
1.7%
17
Circulation
74 papers in training set
Top 1%
1.7%
18
Developmental Biology
150 papers in training set
Top 1%
1.7%
19
Stem Cells
31 papers in training set
Top 0.4%
1.5%
20
Science Advances
1243 papers in training set
Top 25%
1.1%
21
Nature Neuroscience
252 papers in training set
Top 4%
1.1%
22
Nature Cardiovascular Research
33 papers in training set
Top 0.6%
1.1%
23
iScience
1154 papers in training set
Top 25%
1.1%
24
Molecular Therapy
81 papers in training set
Top 1%
1.1%
25
Glia
81 papers in training set
Top 1%
1.0%
26
Journal of Clinical Investigation
179 papers in training set
Top 5%
1.0%
27
EMBO Molecular Medicine
95 papers in training set
Top 3%
0.8%
28
Redox Biology
70 papers in training set
Top 1%
0.8%
29
Journal of Experimental Medicine
119 papers in training set
Top 3%
0.6%
30
Frontiers in Immunology
638 papers in training set
Top 11%
0.6%